Regenxbio Inc. · MUN:RB0

Regenxbio Inc. financial statements

Regenxbio Inc.'s income statement, balance sheet and cash flow, annual and quarterly, each figure dated and linked to the filing it was read from.

Financials

Annual, in USD

Income statement

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Revenue170.4M83.3M90.2M112.7M470.3M154.6M35.2M218.5M10.4M4.59M
Cost of revenue20.3M33.6M37.2M54.5M51.8M35.7M8.24M9.64M1.71M98.0K
Gross profit150.1M49.8M53.0M58.2M418.5M118.9M27.0M208.9M8.68M3.63M
Research and development228.3M208.5M232.3M242.5M181.4M166.3M124.2M83.9M57.2M45.5M
Selling, general and administrative82.9M76.6M88.5M85.3M79.3M63.8M51.8M36.9M27.2M23.6M
Operating income-161.2M-233.3M-268.1M-262.9M160.0M-119.2M-149.0M88.1M-75.9M-65.3M
Depreciation and amortization15.6M16.2M17.3M12.9M9.56M8.41M7.15M3.98M2.69M544.0K
EBITDA-145.6M-217.1M-250.8M-250.0M169.5M-110.8M-141.8M92.1M-73.2M-64.8M
Interest expense45.0M12.7M6.86M23.3M26.3M771.0K107.2M000
Income before tax-193.9M-227.1M-263.6M-280.4M141.2M-106.0M-97.5M104.1M-73.2M-63.4M
Income tax00-152.0K-84.0K13.4M5.24M-2.75M4.18M0-435.0K
Net income-193.9M-227.1M-263.5M-280.3M127.8M-111.3M-94.7M99.9M-73.2M-63.0M
Earnings per share, basic-3.76-4.59-6.02-6.503.01-2.98-2.582.99-2.45-2.38
Earnings per share, diluted-3.76-4.59-6.02-6.502.91-2.98-2.582.73-2.45-2.38

Balance sheet

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash and equivalents34.5M57.5M34.5M97.0M345.2M338.4M69.5M75.6M46.7M24.8M
Short-term investments195.6M177.2M240.7M267.7M112.2M137.3M226.7M244.2M114.1M64.7M
Receivables26.4M20.5M24.8M28.1M32.4M43.0M38.1M8.59M473.0K1.03M
Inventory13.9M18.8M10.5M6.47M5.73M5.33M1.77M
Current assets281.3M278.0M335.0M416.0M518.8M531.2M345.0M337.9M168.0M93.4M
Property, plant and equipment104.9M117.6M132.1M141.7M131.5M56.5M29.0M28.7M14.0M9.32M
Goodwill00
Total assets453.0M466.0M574.0M833.3M1.11B708.2M497.9M543.8M198.7M172.7M
Accounts payable21.4M22.8M22.8M27.2M11.4M10.6M6.41M4.41M4.83M1.54M
Current liabilities118.1M103.2M130.3M130.4M130.5M81.4M33.7M22.2M14.4M9.67M
Long-term debt00
Total debt260.5M82.0M89.3M94.8M86.7M72.7M11.3M5.85M
Total liabilities350.3M206.3M262.2M317.1M349.6M330.4M47.7M35.0M15.6M11.0M
Shareholders' equity102.7M259.7M311.7M516.2M764.3M377.8M450.2M508.8M183.0M161.7M
Shares outstanding50.9M49.5M44.0M43.3M42.8M37.5M37.0M36.1M31.3M26.5M

Cash flow

LineFY2025FY2024FY2023FY2022FY2021FY2020FY2019FY2018FY2017FY2016
Cash from operations-124.0M-173.1M-218.4M-207.5M218.9M-54.1M-107.7M104.6M-58.0M-48.6M
Capital spending-2.41M-2.44M-9.96M-30.7M-84.2M-26.9M-11.7M-13.3M-7.16M-8.15M
Free cash flow-126.4M-175.6M-228.4M-238.2M134.7M-80.9M-119.4M91.4M-65.2M-56.7M
Cash from investing-15.9M103.4M190.9M-11.9M-406.6M122.8M93.6M-279.4M-4.79M19.4M
Cash from financing116.8M92.7M-35.0M-28.8M195.3M200.2M8.38M204.4M84.6M119.0K
Dividends paid00
Share buybacks1.05M1.19M-419.0K-284.0K-2.00K1.80M1.31M847.0K556.0K179.0K
Change in cash-23.1M23.0M-62.4M-248.3M7.48M268.9M-5.77M29.7M21.8M-29.1M